QHM-2025-8474 A86020 Jesmond Health Partnership Enhanced Services Contract

The procurement process of awarding the Jesmond Health Partnership Enhanced Services Contract is overseen by the NHS North East and North Cumbria Integrated Care Board. This initiative focuses on health services under the industry category. The tender, identified as QHM-2025-8474, covers a variety of health services including androgen deprivation injections, PSA monitoring, and diabetes management, among others.

Operating within the United Kingdom's region UKC, the procurement is at the award stage, with a key date of contract signing on 1st October 2025, although services have been delivered since 1st April 2025 on an implied contract. The contract is scheduled to conclude on 31st March 2026. It follows a limited procurement method without prior publication, as per the Health Care Services (Provider Selection Regime) regulations of 2023.

This tender presents potential opportunities for healthcare providers, particularly those capable of delivering specialised health services such as injections and health monitoring. As the procurement method was a direct award with no realistic alternative provider, businesses seeking similar opportunities should ensure alignment with specific service provisions and demonstrate exceptional capability in health services. Organisations with experience in managing integrated care systems and understanding local health demographics, as exemplified by the Jesmond Health Partnership, may find this contract particularly suited to their business growth objectives.

Such contracts, even with unspecified financial guarantees, can fortify a healthcare provider's market presence through collaboration with reputable public health bodies like the NHS.